Coated‐platelet levels are influenced by smoking, aspirin, and selective serotonin reuptake inhibitors
- 1 October 2007
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 5 (10), 2149-2151
- https://doi.org/10.1111/j.1538-7836.2007.02691.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Coated-platelets are Higher in Amnestic Versus Nonamnestic Patients With Mild Cognitive ImpairmentAlzheimer Disease & Associated Disorders, 2007
- Clinical Trials of Neuroprotective TherapiesStroke, 2007
- In-Hospital Initiation of Statin Therapy in Acute Coronary SyndromesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2005
- REVIEW ARTICLE: Coated-platelets: an emerging component of the procoagulant responseJournal of Thrombosis and Haemostasis, 2005
- Prostacyclin prevents nitric oxide‐induced megakaryocyte apoptosisBritish Journal of Pharmacology, 2005
- Inflammation, Immunity, and HMG-CoA Reductase InhibitorsCirculation, 2004
- The pathophysiology of cigarette smoking and cardiovascular disease: An updateJournal of the American College of Cardiology, 2004
- The influence of selective serotonin reuptake inhibitors on human platelet serotoninThrombosis and Haemostasis, 2004
- Reducing global risk for cardiovascular disease: Using lifestyle changes and pharmacotherapyClinical Cardiology, 2002
- Regional and Racial Differences in Response to Antihypertensive Medication Use in a Randomized Controlled Trial of Men With Hypertension in the United StatesArchives of Internal Medicine, 2000